Effects of Eriobotrya japonica seed extract on oxidative stress in rats with non-alcoholic steatohepatitis

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 2, 2010, Pages 241-246

  Yoshioka, Saburo ^a   Hamada, Atsuhide ^a   Jobu, Kohei ^a   Yokota, Junko ^a   Onogawa, Masahide ^a   Kyotani, Shojiro ^a   Miyamura, Mitsuhiko ^a   Saibara, Toshiji ^b   Onishi, Saburo ^b   Nishioka, Yutaka ^a  

^a KOCHI MEDICAL SCHOOL HOSPITAL   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Antioxidant enzyme activity; Eriobotrya japonica seed extract; Methionine choline deficient diet; Non alcoholic steatohepatitis; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLINE; COLLAGEN; DRINKING WATER; ERIOBOTRYA JAPONICA EXTRACT; FAT DROPLET; METHIONINE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; 4-HYDROXY-2-NONENAL; 8-OXO-7-HYDRODEOXYGUANOSINE; ALDEHYDE; ANTIOXIDANT; DEOXYGUANOSINE; PLANT EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATITIS; LIPID PEROXIDATION; LIVER FIBROSIS; LOQUAT; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PLANT SEED; RAT; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ERIOBOTRYA; FATTY LIVER; ISOLATION AND PURIFICATION; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TEST; METABOLISM; ORGAN SIZE; PATHOLOGY; WISTAR RAT;

ALDEHYDES; ANIMALS; ANTIOXIDANTS; BODY WEIGHT; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; ERIOBOTRYA; FATTY LIVER; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TESTS; MALE; ORGAN SIZE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77949623438     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.02.0012     Document Type: Article

References (24)

1. Ludwig J et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980 55 : 434 438
2. Younossi ZM et al. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002 35 : 746 752
3. Kojima S et al. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003 38 : 954 961
4. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?. J Gastroenterol Hepatol 2003 18 : 124 138
5. Day CP, James OFW. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998 114 : 842 845
6. Le TH et al. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2004 39 : 1423 1429
7. Suzuki D et al. Liver failure caused by non-alcoholic steatohepatitis in an obese young male. J Gastroenterol Hepatol 2005 20 : 327 329
8. Marchesini G et al. Metformin in non-alcoholic steatohepatitis. Lancet 2001 358 : 893 894
9. Laurin J et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996 23 : 1464 1467
10. Saibara T et al. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis. Lancet 1999 353 : 1802
11. Yokohama S et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 2004 40 : 1222 1225
12. Hirose A et al. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 2007 45 : 1375 1381
13. Yokota J et al. Scavenging of reactive oxygen species by Eriobotrya japonica seed extract. Biol Pharm Bull 2006 29 : 467 471
14. Takuma D et al. Effect of Eriobotrya japonica seed extract on 5-fluorouracil-induced mucositis in hamsters. Biol Pharm Bull 2008 31 : 250 254
15. Yokota J et al. Gastroprotective activity of Eriobotrya japonica seed extract on experimentally induced gastric lesions in rats. J Nat Med 2008 62 : 96 100
16. Hamada A et al. The effect of Eriobotrya japonica seed extract on oxidative stress in adriamycin-induced nephropathy in rats. Biol Pharm Bull 2004 27 : 1961 1964
17. Sun G et al. Effect of orally administered Eriobotrya japonica seed extract on allergic contact dermatitis in rats. J Pharm Pharmacol 2007 59 : 1405 1412
18. Onogawa M et al. Animal studies supporting the inhibition of mast cell activation by Eriobotrya japonica seed extract. J Pharm Pharmacol 2009 61 : 237 241
19. Nishioka Y. Medicine composition that contains Eriobotrya japonica seed extract to adjust amount of lipid in body fluids. 2003 JP 3438029.
20. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991 91 : 31S 38S
21. Chalasani N et al. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003 37 : 544 550
22. Valenti L et al. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Hepatology 2006 44 : 857 864
23. Nelson JE et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 2007 46 : 723 729
24. Takei Y et al. Choline deficiency and NAFLD. In : Saibara T, ed. Nonalcoholic Fatty Liver Disease: NAFLD - from the base to clinic. Tokyo : Ishiyaku Publishers Inc, 2006 : 159 162.